Historical preconditions of the creation of pharmacovigilance system in
Journal Title: Фармацевтичний журнал - Year 2017, Vol 3, Issue 3
Abstract
The system of pharmacovigilance in the world appeared in response to series of tragedies related to the use of medicines. The largest of these were «sulfanilamide boom», «thalidomide tragedy» and «bomb with time mechanism». In Ukraine, the pharmacovigilance system has existed since 1996, and since 2002 Ukraine has been a member of the WHO international monitoring program for side effects. In 2000–2001 appeared the first orders of the Ministry of Health of Ukraine that regulated the implementation of pharmacovigilance in Ukraine, and in 2007, when the Order of the Ministry of Health of Ukraine № 898 came into force, the legislative framework in the pharmacovigilance system has been radically changed. This is connected with the reflection of the provisions of Directive 2001/83 / EC of the European Parliament and of the Council on the Community code relating to medicinal products in the order № 898. Today, the development of pharmacovigilance in Ukraine is carried out through adaptation to European legislation, which is stipulated by the Law of Ukraine «On the National Program of Adaptation of Ukrainian Legislation to the Law of the European Union».
Authors and Affiliations
N. V. Sholoiko, O. V. Matvieieva, K. S. Haiduk
Analysis of the dynamics structure of National formulary of medicines
For effective functioning in modern conditions the Concept of rational use of medicines, formulated by the WHO's initiative in 1985, requires cooperation of three basic components: the formulary system, the list of essen...
Antiepileptic drugs: interaction, specificity of application
When carrying out the pharmaceutical care of a particular patient (for example, an epileptic patient), the doctor and pharmacist must take into account the possible fact of interaction between anticonvulsants among thems...
Spectral response аnd electronic structure оf synthetic coumarin derivatives. P a r t IV. Study оf the UV-spectra оf warfarin sodium clathrate
Warfarin is a vitamin K antagonist that was first developed by Wisconsion Alunini Research Foundation in 1947. The use of warfarin in the treatment fоr decrease blood clotting, promotes the emergence of a number of side...
Research of medicinal products of the nsaid of the pharmaceutical market in Ukraine for the period 2014–2018
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) are groups of different chemical structures of drugs (derivatives of acids) that are widely used in clinical practice. More than three million people in the world take NSAIDs...
Quantitative determination of glycine in pharmaceutical formulations by reaction with 2,3-dichlor-1,4-naphthoquinone reagent
Glycine has been reported to be determined by different techniques including titrimetric methods, VIS spectrophotometry. Some of the proposed methods require inaccessible reagents, others – difficult in execution or offe...